Меню
Набор скоро начнётся NCT06728839

Efficacy, Safety and Tolerability of Magnesium Sulfate With Low-volume Polyethylene Glycol for Colonoscopy Cleansing

Без фазы С лечением Bowel Preparation for Colonoscopy

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: 1L PEG + 50g magnesium sulfate, 3L PEG, 4L PEG.
Кому может быть актуально
Состояния в реестре: Bowel Preparation for Colonoscopy. Базовые параметры: 18 лет — 75 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Список центров уточняется — проверьте первичный протокол.
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Efficacy, Safety and Tolerability of Magnesium Sulfate With Low-volume Polyethylene Glycol for Bowel Preparation Before Colonoscopy: A Multicentre, Randomized, Controlled Trial

Обзор

Magnesium salts such as magnesium citrate are often combined with polyethylene glycol to make the intestinal preparation before colonoscopy, which has shown high cleaning efficacy. Magnesium sulfate combined with polyethylene glycol is less used in the world. This multicenter, randomized, controlled trial is aimed at to evaluate the efficacy and safety of magnesium sulfate combined with low-volume polyethylene glycol for preoperative bowel preparation for colonoscopy.

Вмешательства

  • Препарат 1L PEG + 50g magnesium sulfate
    Subjects in Group A will use a regimen combining magnesium sulfate and polyethylene glycol for preoperative bowel preparation and undergo colonoscopy. 1 litter of polyethylene glycol is taken at 8pm the day before the colonoscopy and 50 gram of magnesium sulfate is taken 4-6 hours before the colonoscopy, and then drink 2000 ml of water within 2 hours.
  • Препарат 3L PEG
    Subjects in Group B will use a regimen with 3L polyethylene glycol for preoperative bowel preparation and undergo colonoscopy. The 3 liters of polyethylene glycol solution is taken in split dosing, with 1 liter taken at 8pm the day before the colonoscopy and 2 liters taken 4-6 hours before the colonoscopy.
  • Препарат 4L PEG
    Subjects in Group C will use a regimen with 4L polyethylene glycol for preoperative bowel preparation and undergo colonoscopy. The 4 liters of polyethylene glycol solution is taken in split dosing, with 2 liters taken at 8pm the day before the colonoscopy and 2 liters taken 4-6 hours before the colonoscopy.

Первичные конечные точки

  • Adequate bowel preparation rate [Срок оценки: 30minutes]
Вторичные конечные точки (5)
  • Excellent bowel preparation rate [Срок оценки: 30minutes]
  • BBPS score (including total score, left colon, transverse colon, and right colon) [Срок оценки: 30minutes]
  • Adenoma detection rate [Срок оценки: 10 days]
  • Bowel preparation completion rate [Срок оценки: 30minutes]
  • Electrolyte levels [Срок оценки: 8 hours]

Критерии участия

Критерии включения

  • 18-75 years old, male or female
  • To undergo screening, surveillance and diagnostic colonoscopy
  • Signed written informed consent

Критерии исключения

  • Subjects with therapeutic colonoscopy for colorectal polyps
  • Subjects with confirmed or suspected gastrointestinal obstruction, gastric retention, gastroparesis, gastric emptying disorder, or acute gastrointestinal bleeding
  • Subjects with confirmed or suspected colorectal cancer, inflammatory bowel disease, toxic colitis, or toxic megacolon
  • Subjects with renal or liver dysfunction, congestive heart failure or rhabdomyolysis
  • Subjects with ascites, suspected electrolyte abnormalities, or uncorrected dehydration
  • Subjects with constipation (<3 times a week, difficult defecation, dry stool, less amount)
  • Subjects with serious cardiac and cerebrovascular diseases,suffering from metabolic disease or endocrine disease
  • Subjects who had previously undergone colorectal resection
  • Women with positive pregnancy tests or pregnancy plans, and women in lactation or allergic to the investigational drugs and their ingredients
  • Subjects who are participating in other clinical trials or receiving special drugs
  • Subjects with any other conditions that the investigator considered inappropriate for inclusion

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Да

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Простое слепое
Основная цель
Диагностика

Центры проведения

Список центров уточняется — проверьте первичный протокол.

Публикации

  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. PMID 33538338
  • Ge F, Kang X, Wang Z, Zhu H, Liao L, Wang M, Jia J, Lou L, Guo X, Pan Y, Wan J. Low-dose of magnesium sulfate solution was not inferior to standard regime of polyethylene glycol for bowel preparation in elderly patients: a randomized, controlled study. Scand J Gastroenterol. 2023 Jan;58(1):94-100. doi: 10.1080/00365521.2022.2106154. Epub 2022 Aug 3. PMID 35920250
  • Park SS, Sinn DH, Kim YH, Lim YJ, Sun Y, Lee JH, Kim JY, Chang DK, Son HJ, Rhee PL, Rhee JC, Kim JJ. Efficacy and tolerability of split-dose magnesium citrate: low-volume (2 liters) polyethylene glycol vs. single- or split-dose polyethylene glycol bowel preparation for morning colonoscopy. Am J Gastroenterol. 2010 Jun;105(6):1319-26. doi: 10.1038/ajg.2010.79. Epub 2010 May 18. PMID 20485282

Идентификаторы

NCT: NCT06728839 · MGSP-2024

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗